Cysteine Modification by Ebselen Reduces the Stability and Cellular Levels of 14-3-3 Proteins-Reference-Cited by-同舟云学术

Cysteine Modification by Ebselen Reduces the Stability and Cellular Levels of 14-3-3 Proteins

Published:2021-05-24 Issue:2 Volume:100 Page:155-169
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Waløen Kai,Jung-KC Kunwar,Vecchia Elisa D.,Pandey Sunil,Gasparik Norbert,Døskeland Anne,Patil Sudarshan,Kleppe Rune,Hritz Jozef,Norton William H.J.,Martinez Aurora,Haavik Jan

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference65 articles.

1. 14-3-3 proteins: A historic overview

2. Discovery of a specific inhibitor of pyomelanin synthesis in Legionella pneumophila;Aubi;J Med Chem,2015

3. Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways

4. 14-3-3: A Case Study in PPI Modulation

5. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ebselen improves lipid metabolism by activating PI3K/Akt and inhibiting TLR4/JNK signaling pathway to alleviate nonalcoholic fatty liver;Cytokine;2024-09

2. Covalent hits and where to find them;SLAS Discovery;2024-04

3. The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders;Neurochemistry International;2023-12

4. The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria and tyrosinemia type 1;2023-09-05

5. Selenium-Containing Agents Acting on Cancer—A New Hope?;Pharmaceutics;2022-12-28